Risk factor
Poor trading liquidity
Profitability factor
Favourable analyst view
About
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is of fair value on EV/EBITDA.
Target Price
The average target price of ATRY.MC is 5.7 and suggests 91% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell